�terna Zentaris, Inc.(Toronto Stock Exchange : AEZS)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.88% | 93.92 | 1.3% | $988.55m | |
| BIIB | Biogen Inc. | 2.45% | 229.89 | 1.3% | $619.18m | |
| AMGN | Amgen Inc. | 1.22% | 180.48 | 1.3% | $474.61m | |
| GILD | Gilead Sciences, Inc. | 2.13% | 64.14 | 0.9% | $448.87m | |
| ILMN | Illumina, Inc. | 1.49% | 319.20 | 3.5% | $295.43m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.80% | 349.99 | 2.6% | $291.08m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.18% | 174.61 | 1.9% | $236.35m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 4.30% | 135.68 | 2.0% | $176.60m | |
| EXAS | Exact Sciences Corporation | 0.27% | 95.39 | 25.3% | $169.11m | |
| A | Agilent Technologies, Inc. | 1.23% | 76.72 | 1.6% | $147.38m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.74% | 120.22 | 14.7% | $129.47m | |
| ONCE | Spark Therapeutics, Inc. | 0.64% | 111.38 | 11.2% | $116.56m | |
| INCY | Incyte Corporation | 0.57% | 73.94 | 2.5% | $97.68m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.72% | 73.86 | 8.3% | $96.82m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.21% | 85.31 | 4.3% | $92.88m |
Company Profile
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.